Synthetic IL-20 peptide demonstrates potent, stable, and safe antimicrobial activity against *Vibrio anguillarum*
Background
The rapid expansion of aquaculture has led to increased disease outbreaks, particularly bacterial infections, posing significant threats to global food security. Vibrio anguillarum is a major pathogen in marine aquaculture, and widespread antibiotic resistance limits effective therapeutic options. This necessitates innovative and sustainable disease control strategies. Antimicrobial peptides (AMPs) offer a promising alternative due to their broad-spectrum activity and distinct mechanisms that may circumvent traditional resistance pathways, addressing a critical gap in current aquaculture disease management.
Study Design
Researchers synthesized the IL-20 peptide via solid-phase Fmoc chemistry, achieving >96% purity. Physicochemical and structural properties were predicted using PepCalc, PEP-FOLD3, RAMPAGE, and HeliQuest. In silico antimicrobial potential was assessed with CAMPR3, APD3, and iAMPprep. Molecular docking (HDOCK) identified binding targets within V. anguillarum proteins. In vitro assays included MIC determination against V. anguillarum isolates, stability tests (varied temperatures, protease exposure), cytotoxicity (MTT), hemolysis, bacterial DNA binding, biofilm inhibition, and time-kill kinetics.
Results
The IL-20 peptide exhibited a consistent MIC of 4 μg mL-1 against V. anguillarum isolates. In silico analysis predicted strong antimicrobial potential, confirmed by molecular docking showing strong binding to V. anguillarum proteins TDH-related hemolysin and Aspartate β-semialdehyde dehydrogenase with high scores and multiple hydrogen/hydrophobic interactions. Stability assays demonstrated retained activity across varied temperatures and partial protease resistance.
IL-20 showed low cytotoxicity and minimal hemolytic effect in
MTTand hemolysis assays, confirming its safety profile. Furthermore, IL-20 bound bacterial DNA and significantly inhibited biofilm formation. Time-kill kinetics revealed rapid bactericidal action, eliminating bacteria within hours, highlighting its potent and swift antimicrobial efficacy.
Key Findings
- IL-20 peptide achieved >96% purity and confirmed helical, amphipathic structure with a +10 net charge.
- IL-20 demonstrated a consistent MIC of 4 μg mL-1 against Vibrio anguillarum isolates.
- Molecular docking showed strong binding of IL-20 to
TDH-related hemolysinandAspartate β-semialdehyde dehydrogenasein V. anguillarum. - IL-20 retained activity at varied temperatures and showed partial protease resistance.
- IL-20 exhibited low cytotoxicity and minimal hemolytic effect, bound bacterial DNA, and significantly inhibited biofilm formation.
Why It Matters
This study highlights IL-20 as a promising, safe, and stable antimicrobial peptide, offering a vital alternative to conventional antibiotics in aquaculture. Developing IL-20 as a therapeutic agent could significantly reduce antibiotic reliance and combat resistance in fish farming. For biohackers or those interested in novel antimicrobial strategies, this demonstrates the potential of rationally designed AMPs to target specific pathogens effectively. While preclinical, these findings lay the groundwork for future in vivo studies, potentially leading to new protocols for preventing and treating bacterial infections in aquatic systems, enhancing sustainability and food security.
il-20
antimicrobial peptide
vibrio anguillarum
aquaculture
antibiotic resistance
in vitro